Generics
Esperion settles with Dr. Reddy's Laboratories on NEXLETOL and NEXLIZET generics
3 October 2025 - US commercial stage biopharmaceutical company Esperion Therapeutics Inc (NASDAQ:ESPR) on Friday announced a settlement with Indian pharmaceutical company Dr. Reddy's Laboratories...
Mint Pharmaceuticals forms distribution partnership with Bayer Canada
26 September 2025 - Canadian generic pharmaceuticals company Mint Pharmaceuticals Inc announced on Thursday that it has agreed a new distribution partnership with Bayer Canada, a subsidiary of German ...
Padagis collaborates with The Naloxone Project to address opioid overdose crisis
24 September 2025 - Generic pharmaceuticals company Padagis announced on Tuesday a new partnership with The Naloxone Project (TNP), a clinician-led, nonprofit organisation dedicated to transforming th...
Zentiva announces sale from Advent to GTCR
12 September 2025 - Generics pharmaceutical company Zentiva, together with private equity investors Advent and GTCR, on Thursday announced the sale of Zentiva by Advent to GTCR.Since acquiring Zentiva...
Biocon's first US manufacturing facility inaugurated in Cranbury, New Jersey
11 September 2025 - Biocon Limited (BSE:532523) (NSE:BIOCON), an India-based global biopharmaceutical company, announced on Wednesday the inauguration of its first US manufacturing facility in Cranbur...
Amneal's risperidone extended-release injectable suspension approved by US FDA
5 September 2025 - Biopharmaceutical company Amneal Pharmaceuticals Inc announced on Thursday that the US Food and Drug Administration (FDA) has approved risperidone extended-release injectable suspen...